Thu, 19th May 2022 16:05
LONDON, May 19 (Reuters) - The European health regulator on Thursday endorsed the use of AstraZeneca's COVID vaccine, Vaxzevria, as a booster.
The recommendation encompasses adults who have either been previously vaccinated by Vaxzevria or an mRNA vaccine, such as the ones made by Pfizer and BioNTech or Moderna. (Reporting by Natalie Grover in London; Editing by Angus MacSwan)
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:
INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company rep...
(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract c...
April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugel...
Astrazeneca (AZN)